Mohammad Jad Moussa

8PUBLICATIONS
36CO-AUTHORS
Cancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 30, 2026
Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability.

Mohammad Jad Moussa, Alexander Y Andreev-Drakhlin, Aradhana M Venkatesan

|Mar 04, 2025
Antiangiogenic therapy combined with immune checkpoint blockade in urothelial cancer: Systematic review and meta-analysis.

Mohammad Jad Moussa, Iuliia Kovalenko, Emanuele Crupi

|Feb 12, 2025
Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma.

Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson

|Jan 20, 2025
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract.

Mohammad Jad Moussa, Georges C Tabet, Arlene O Siefker-Radtke

|Sep 09, 2024
Antiangiogenic Tyrosine Kinase Inhibitors have Differential Efficacy in Clear Cell Renal Cell Carcinoma in Bone.

Stefan Maksimovic, Nina C Boscolo, Ludovica La Posta

|Jul 27, 2024
Brain Metastasis in the Emergency Department: Epidemiology, Presentation, Investigations, and Management.

Marianne Zoghbi, Mohammad Jad Moussa, Jim Dagher

Pageof 2

Frequent Collaborators

6 joint publications

Omar Alhalabi

4 joint publications

Matthew T Campbell

4 joint publications

Pavlos Msaouel

2 joint publications

Nizar M Tannir